Vendor, Ithaca, NY
Jan Biotech, Inc.
UEI DKDUTDKCJQE6, CAGE 71ZJ8
1 award and $3,000,000 obligated between September 12, 2024 and June 1, 2026, 100% under full and open competition, against 3.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $3,000,000 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942524C0079Definitive Contract, September 12, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | Army Med Res Acq ActivityDefense Health Agency | DHA SBIR Direct Phase II H2D-0219 Sample Collection and Processing Methods to Support Battlefield Wound Infection DiagnosticsNAICS 541715, PSC AN12 | $3,000,000 |
- Places of performance
- New York
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 3 across 1 awards